SA-4-1BBL

N/A

Report date: 2025/01/26 17:10:46

Base Information

Drug NameSA-4-1BBL
Drug Alias NameImmune checkpoint stimulator (University of Louisville/FasCure)4-1BB costimulator (University of Louisville/FasCure Therapeutics)SA-4-1BBL
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionTumor necrosis factor receptor superfamily member 9 stimulants
TargetsTumor necrosis factor receptor superfamily member 9
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Louisville
China Registration ClassN/A

Develop Information

Active CompaniesFasCure Therapeutics LLCUniversity Of Louisville
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A